Drugmaker Organon has loosened its 340B contract pharmacy restrictions in Arkansas and Louisiana in response to state laws.
Sixth Drugmaker Loosens 340B Contract Pharmacy Restrictions in Arkansas and Louisiana
Organon, a Merck spinoff with a focus on women’s health, yesterday became the sixth drugmaker to loosen or end its [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.